Posted:
#101
I thought so too!! If you are going alt energy, take more chances than those holdings!!!
October Stock Talk II
Posted:
#105
Quote Originally Posted by Vermeer:
I thought so too!! If you are going alt energy, take more chances than those holdings!!!
I thought so too!! If you are going alt energy, take more chances than those holdings!!!
You guys have any other alt energy suggesting, not individual stocks, but a basket of them, either ETF or mutual fund?
On a separate note, check out this article on Sequenom out today on a note from Oppenheimer. Stock is up almost 10% today....
Oppenheimer is out with a nice call on Sequenom (NASDAQ:SQNM) after they were able to meet with a portion of the company's management last week. According to the firm the company is making strong progress towards its Down's Syndrome diagnostic prenatal test. They believe this is a potentially ground-breaking test that could revolutionize testing within the prenatal medical arena. Additionally, Sensigen continues to work towards a more specific HPV test. Finally, the company's new nanopore sequencing technology should add another stream of revenue in the future.
Firm views the development in Down's as very positive for investors, as previously the test had simply been a concept. The company will now find additional SNPs to utilize in order to create a test that works in everyone. OpCo expects the company may release interim data at the Society for Maternal Fetal Medicine annual meeting in Dallas at the end of January.
Based on these developments the firm feels they need to adjust their price target and the multiple they use to derive it. Firm believes the Down's test will produce most of Sequenom's revenue in the near future, and now that they believe the chance of a successful test being developed has increased, they are increasing their multiple. OpCo now increases their price target to $15 from $10.
In seeking comparable companies, the firm believes Hemosense (HEM) and Genomic Health (GHDX) are similar, with the ability to change how certain areas of medicine are practiced.
Notablecalls: This is the kind of call that will generate enough interest to push SQNM toward the $9.50-$10 level in the short term.
Posted:
#107
Depeche,
I am pretty pissed about missing the SQNM order that day..its up about 40% from that price..and it rarely drops to any degree.
Nice job, I hope you have a zillion shares to make it worth your while.
And I dont mind that ETF being conservative..it needs to be weighted that way, if it were more aggressive it would get in trouble by investors if the group dropped. So yeah it makes sense to me, but it is too conservative for what I would like.. I would like to see a higher weighting in better performing stocks. It almost seems like they have a market cap weighting..so they are trying to balance the fund/investment.
I am pretty pissed about missing the SQNM order that day..its up about 40% from that price..and it rarely drops to any degree.
Nice job, I hope you have a zillion shares to make it worth your while.
And I dont mind that ETF being conservative..it needs to be weighted that way, if it were more aggressive it would get in trouble by investors if the group dropped. So yeah it makes sense to me, but it is too conservative for what I would like.. I would like to see a higher weighting in better performing stocks. It almost seems like they have a market cap weighting..so they are trying to balance the fund/investment.
Hot Forum Topics
